Company Announcements

UDG Healthcare PLC 38.5a

Source: RNS
RNS Number : 5630Y
JPMorgan Securities Plc
13 May 2021
 

Ap24

 

FORM 38.5(a)

 

       IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY

 

1.       KEY INFORMATION

 

Name of exempt principal trader

J.P. Morgan Securities Plc

Company dealt in

UDG Healthcare Plc

Class of relevant security to which the dealings being disclosed relate (Note 1)

Ordinary Stock

Date of dealing

12 May 2021

 

2.        DEALINGS (Note 2)

 

(a)      Purchases and sales

 

Total number of relevant securities acquired

Highest price paid (Note 3)

Lowest price paid

(Note 3)

5,317,364

10.3900 GBP

8.4200 GBP

 

 

Total number of securities disposed

Highest price received (Note 3)

Lowest price received

(Note 3)

9,868

 

4,373,413

13.6514 USD

 

10.3600 GBP

13.4324 USD

 

8.4200 GBP

 

 

(b)      Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 4)

Number of relevant securities

(Note 5)

Price per unit

(Note 3)

Ordinary shares

Decrease Long

 

 

 

 

 

 

 

 

 

Decrease Short

 

 

 

 

 

 

 

 

 

 

Increase Long

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Increase Short

 

 

 

 

 

 

 

 

 

Opening a short position

 

 

 

 

20,292

 3,174

 1,975

 7,335

 8,577

 1,207

 6,544

 218

 54

 

 38,830

 828

 18,154

 550

 38,830

 6,200

 2,951

 516

 880

 9,634

 

 19

 61

 1,511

 5,001

 369

 1,951

 619

 10,445

 649

 358

 419

 11,664

 2,217

 8,045

 195

 5,302

 791

 868

 109

 225

 

 210

 25,000

 46

 40

 245,954

 14,676

 20,000

 28,511

 5,854

 

 45,000

 16,500

 16,500

 350,000

 20,000

 1,129

 112,500

 75,000

 16,500

10.1600        GBP

 10.1605       GBP

 10.1855       GBP

 10.2070       GBP

 10.2072       GBP

 10.2125       GBP

 10.2230       GBP

 10.2301       GBP

 10.2406       GBP

 

 10.1639       GBP

 10.1857       GBP

 10.2123       GBP

 10.2152       GBP

 10.2538       GBP

 10.2591       GBP

 10.2848       GBP

 10.2998       GBP

 10.3127       GBP

 10.3201       GBP

 

 10.1600       GBP

 10.1636       GBP

 10.1700       GBP

 10.1787       GBP

 10.1794       GBP

 10.1800       GBP

 10.1805       GBP

 10.1896       GBP

 10.2031       GBP

 10.2095       GBP

 10.2097       GBP

 10.2102       GBP

 10.2103       GBP

 10.2104       GBP

 10.2447       GBP

 10.2502       GBP

 10.2507       GBP

 10.2668       GBP

 10.2899       GBP

 10.2994       GBP

 

 10.1600       GBP

 10.1602       GBP

 10.1765       GBP

 10.1813       GBP

 10.1815       GBP

 10.1993       GBP

 10.2211       GBP

 10.2344       GBP

 10.2918       GBP

 

 10.1684       GBP

 10.1701       GBP

 10.1751       GBP

 10.1804       GBP

 10.1934       GBP

 10.1952       GBP

 10.2205       GBP

 10.2259       GBP

 10.3152       GBP

 

Ap25

 

(c)      Options transactions in respect of existing relevant securities

 

 

(i)       Writing, selling, purchasing or varying

 

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 5)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 3)

 

 

 

 

 

 

 

 

 

(ii)      Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 3)

 

 

 

 

 

3.      OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the 

voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition 

or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

Date of disclosure

13 May 2021

Contact name

Alwyn Basch

Telephone number

020 7742 7407

Name of offeree/offeror with which connected

UDG Healthcare Plc

Nature of connection (Note 6)

Financial adviser to CD&R Fund XI

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEAJMMTMTABBPB